Sex Differences in Coronary Inflammation and Clinical Outcomes Among Patients with Plaque-Positive Non-Obstructive

Bowen Li1,2, Yong Chen3, Xueqiao Yang1,2

  • 1Shandong First Medical University (Shandong Academy of Medical Sciences), Jinan Shandong 250117, China.

Insights

Males with non-obstructive coronary artery disease (CAD) show higher coronary inflammation and worse outcomes than females. The pericoronary fat attenuation index (pFAI) predicts prognosis in these patients.

Area of Science:

  • Cardiology
  • Radiology
  • Medical Imaging

Background:

  • Sex differences in coronary inflammation in non-obstructive coronary artery disease (CAD) are not well understood.
  • Coronary inflammation assessment using pericoronary fat attenuation index (pFAI) from coronary computed tomography angiography (CCTA) is emerging.
  • This study investigates sex-based disparities in coronary inflammation and their clinical impact in plaque-positive non-obstructive CAD.

Purpose of the Study:

  • To determine sex differences in coronary inflammation using pFAI in patients with non-obstructive CAD.
  • To evaluate the impact of sex-specific coronary inflammation on major adverse cardiovascular events (MACEs).
  • To assess the prognostic value of pFAI in risk stratification for non-obstructive CAD.

Main Methods:

  • Retrospective analysis of 1395 patients with plaque-positive non-obstructive CAD who underwent CCTA.
  • Coronary inflammation quantified by pFAI (HU).
  • Major adverse cardiovascular events (MACEs) tracked over a median of 85 months.

Main Results:

  • Male sex was independently linked to higher coronary inflammation (pFAI > -70.1 HU) and increased MACE risk.
  • Patients with coronary inflammation (pFAI > -70.1 HU) had significantly worse long-term outcomes, consistent across sexes.
  • pFAI independently predicted MACEs in non-obstructive CAD, offering incremental prognostic value beyond clinical and traditional CCTA metrics.

Conclusions:

  • Males with non-obstructive CAD exhibit greater coronary inflammation and poorer outcomes compared to females.
  • pFAI is a significant independent predictor of long-term prognosis in non-obstructive CAD.
  • pFAI enhances risk stratification for patients with plaque-positive non-obstructive CAD.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...